Follow
Shakila Meshkat
Shakila Meshkat
St. Michael's Hospital, Unity Health Toronto
Verified email at unityhealth.to
Title
Cited by
Cited by
Year
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Y Alnefeesi, D Chen-Li, E Krane, MY Jawad, NB Rodrigues, F Ceban, ...
Journal of Psychiatric Research, 2022
1322022
Registered clinical studies investigating psychedelic drugs for psychiatric disorders
AN Siegel, S Meshkat, K Benitah, O Lipsitz, H Gill, LMW Lui, KM Teopiz, ...
Journal of Psychiatric Research 139, 71-81, 2021
832021
Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker of Treatment Response in Patients with Treatment Resistant Depression (TRD): A Systematic Review & Meta-analysis
S Meshkat, Y Alnefeesi, MY Jawad, JD Di Vincenzo, NB Rodrigues, ...
Psychiatry Research, 114857, 2022
452022
Active mechanisms of ketamine-assisted psychotherapy: A systematic review
I Joneborg, Y Lee, JD Di Vincenzo, F Ceban, S Meshkat, LMW Lui, ...
Journal of Affective Disorders, 2022
412022
Oral Ketamine for Depression: An Updated Systematic Review
S Meshkat, S Haikazian, J D. Di Vincenzo, F Fancy, D Johnson, ...
The World Journal of Biological Psychiatry, 1-36, 2023
342023
The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review
A Mckenzie, S Meshkat, LMW Lui, R Ho, JD Di Vincenzo, F Ceban, B Cao, ...
Journal of Psychiatric Research, 2022
312022
Pharmacogenomics of ketamine: A systematic review
S Meshkat, NB Rodrigues, JD Di Vincenzo, F Ceban, S Jaberi, ...
Journal of Psychiatric Research 145, 27-34, 2022
272022
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin
JD Rosenblat, S Meshkat, Z Doyle, E Kaczmarek, RM Brudner, K Kratiuk, ...
Med, 2024
242024
The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
MY Jawad, JD Di Vincenzo, S Badulescu, KM Teopiz, A Tabassum, ...
Neuropharmacology, 109299, 2022
242022
Real World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Depression with Comorbid Borderline Personality Disorder
K Danayan, N Chisamore, NB Rodrigues, JD Di Vincenzo, S Meshkat, ...
Psychiatry Research, 115133, 2023
232023
The Bi-directional Association of Nonalcoholic Fatty Liver Disease with Depression, Bipolar Disorder and Schizophrenia.
MY Jawad, S Meshkat, A Tabassum, A Mckenzie, JD Di Vincenzo, Z Guo, ...
CNS Spectrums, 1-44, 2022
202022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review
A Levinta, S Meshkat, RS McIntyre, C Ho, LMW Lui, Y Lee, RB Mansur, ...
Journal of Affective Disorders, 2022
192022
Chronic neurological diseases and COVID-19: Associations and considerations
S Meshkat, A Salimi, A Joshaghanian, S Sedighi, S Sedighi, ...
Translational Neuroscience 11 (1), 294-301, 2020
192020
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
S Meshkat, KM Teopiz, JD Di Vincenzo, JBB Bailey, JD Rosenblat, RC Ho, ...
Journal of Affective Disorders, 2023
162023
Biomarkers of ketamine's antidepressant effect: An umbrella review
S Meshkat, RC Ho, B Cao, KM Teopiz, JD Rosenblat, TG Rhee, ...
Journal of Affective Disorders, 2022
142022
Ketamine Use in Pediatric Depression: A Systematic Review
S Meshkat, JD Rosenblat, RC Ho, TG Rhee, B Cao, F Ceban, K Danayan, ...
Psychiatry Research, 114911, 2022
142022
Idiopathic superficial siderosis of the central nervous system
S Meshkat, P Ebrahimi, A Tafakhori, A Taghiloo, S Shafiee, A Salimi, ...
Cerebellum & Ataxias 8 (1), 1-5, 2021
132021
Cognitive Impairment in Opium Use Disorder
H Sanjari Moghaddam, B Shadloo, H Shahkhah, A Tafakhori, ...
Behavioural Neurology 2021, 2021
122021
Descriptive Epidemiology of Brain and Central Nervous System Tumours: Results from Iran National Cancer Registry, 2010-2014
A Salimi, A Zali, AS Seddighi, A Seddighi, S Meshkat, M Hosseini, ...
Journal of Cancer Epidemiology 2020, 2020
122020
Sex Differences in Ketamine's Therapeutic Effects for Mood Disorders: A Systematic Review
K Benitah, AN Siegel, O Lipsitz, NB Rodrigues, S Meshkat, Y Lee, ...
Psychiatry Research, 114579, 2022
112022
The system can't perform the operation now. Try again later.
Articles 1–20